Retinitis Pigmentosa (RP) Terminated Phase 3 Trials for Unoprostone (DB06826)

Also known as: Retinitis Pigmentosa / Pigmentary maculopathy / Albipunctate retinal dystrophy

IndicationStatusPhase
DBCOND0056216 (Retinitis Pigmentosa (RP))Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01786395Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis PigmentosaTreatment